| 211 |
GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. |
2011 |
| 212 |
GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. |
2011 |
| 213 |
GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. |
2011 |
| 214 |
Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response |
2011 |
| 215 |
Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response |
2011 |
| 216 |
Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response |
2011 |
| 217 |
PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER |
2011 |
| 218 |
PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER |
2011 |
| 219 |
PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER |
2011 |
| 220 |
PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER |
2011 |